Cyclerion Therapeutics (CYCN) Asset Writedowns and Impairment (2023)
Cyclerion Therapeutics (CYCN) recorded quarterly Asset Writedowns and Impairment of $3.3 million in Q3 2023.
Cyclerion Therapeutics (CYCN) Asset Writedowns and Impairment (2023) Analysis & Trends
Cyclerion Therapeutics' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $3.3 million for Q3 2023.
- In Q3 2023, Asset Writedowns and Impairment changed N/A year-over-year to $3.3 million; the TTM figure through Dec 2024 stood at $3.3 million (changed 0.0% YoY), while the FY2023 annual figure was $3.3 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $3.3 million for Q3 2023 at Cyclerion Therapeutics.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $3.3 million in Q3 2023 to a low of $3.3 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 3.30 Mn |
| Sep 30, 2023 | 3.30 Mn |